Gabriela Vazquez-Benitez1, Jay R Desai2, Stanley Xu3, Glenn K Goodrich3, Emily B Schroeder3, Gregory A Nichols4, Jodi Segal5, Melissa G Butler6, Andrew J Karter7, John F Steiner3, Katherine M Newton8, Leo S Morales9, Ram D Pathak10, Abraham Thomas11, Kristi Reynolds12, H Lester Kirchner13, Beth Waitzfelder14, Jennifer Elston Lafata15, Renuka Adibhatla2, Zhiyuan Xu2, Patrick J O'Connor2. 1. HealthPartners Institute for Education and Research, Minneapolis, MN gabriela.x.vazquezbenitez@healthpartners.com. 2. HealthPartners Institute for Education and Research, Minneapolis, MN. 3. Kaiser Permanente Institute for Health Research, Denver, CO. 4. Kaiser Permanente Center for Health Research, Portland, OR. 5. Johns Hopkins Medicine, Baltimore, MD. 6. Kaiser Permanente Georgia, Center for Health Research Southeast, Atlanta, GA. 7. Division of Research, Kaiser Permanente Northern California, Oakland, CA. 8. Group Health Research Institute, Seattle, WA. 9. University of Washington School of Medicine, Seattle, WA. 10. Department of Endocrinology, Marshfield Clinic, Marshfield, WI. 11. Lutheran Medical Center, Brooklyn, NY. 12. Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA. 13. Geisinger Health System, Danville, PA. 14. Kaiser Permanente Center for Health Research, Honolulu, HI. 15. Lutheran Medical Center, Brooklyn, NY Virginia Commonwealth University School of Medicine, Richmond, VA.
Abstract
OBJECTIVE: The objective of this study was to assess the incidence of major cardiovascular (CV) hospitalization events and all-cause deaths among adults with diabetes with or without CV disease (CVD) associated with inadequately controlled glycated hemoglobin (A1C), high LDL cholesterol (LDL-C), high blood pressure (BP), and current smoking. RESEARCH DESIGN AND METHODS: Study subjects included 859,617 adults with diabetes enrolled for more than 6 months during 2005-2011 in a network of 11 U.S. integrated health care organizations. Inadequate risk factor control was classified as LDL-C ≥100 mg/dL, A1C ≥7% (53 mmol/mol), BP ≥140/90 mm Hg, or smoking. Major CV events were based on primary hospital discharge diagnoses for myocardial infarction (MI) and acute coronary syndrome (ACS), stroke, or heart failure (HF). Five-year incidence rates, rate ratios, and average attributable fractions were estimated using multivariable Poisson regression models. RESULTS: Mean (SD) age at baseline was 59 (14) years; 48% of subjects were female, 45% were white, and 31% had CVD. Mean follow-up was 59 months. Event rates per 100 person-years for adults with diabetes and CVD versus those without CVD were 6.0 vs. 1.7 for MI/ACS, 5.3 vs. 1.5 for stroke, 8.4 vs. 1.2 for HF, 18.1 vs. 40 for all CV events, and 23.5 vs. 5.0 for all-cause mortality. The percentages of CV events and deaths associated with inadequate risk factor control were 11% and 3%, respectively, for those with CVD and 34% and 7%, respectively, for those without CVD. CONCLUSIONS: Additional attention to traditional CV risk factors could yield further substantive reductions in CV events and mortality in adults with diabetes.
OBJECTIVE: The objective of this study was to assess the incidence of major cardiovascular (CV) hospitalization events and all-cause deaths among adults with diabetes with or without CV disease (CVD) associated with inadequately controlled glycated hemoglobin (A1C), high LDL cholesterol (LDL-C), high blood pressure (BP), and current smoking. RESEARCH DESIGN AND METHODS: Study subjects included 859,617 adults with diabetes enrolled for more than 6 months during 2005-2011 in a network of 11 U.S. integrated health care organizations. Inadequate risk factor control was classified as LDL-C ≥100 mg/dL, A1C ≥7% (53 mmol/mol), BP ≥140/90 mm Hg, or smoking. Major CV events were based on primary hospital discharge diagnoses for myocardial infarction (MI) and acute coronary syndrome (ACS), stroke, or heart failure (HF). Five-year incidence rates, rate ratios, and average attributable fractions were estimated using multivariable Poisson regression models. RESULTS: Mean (SD) age at baseline was 59 (14) years; 48% of subjects were female, 45% were white, and 31% had CVD. Mean follow-up was 59 months. Event rates per 100 person-years for adults with diabetes and CVD versus those without CVD were 6.0 vs. 1.7 for MI/ACS, 5.3 vs. 1.5 for stroke, 8.4 vs. 1.2 for HF, 18.1 vs. 40 for all CV events, and 23.5 vs. 5.0 for all-cause mortality. The percentages of CV events and deaths associated with inadequate risk factor control were 11% and 3%, respectively, for those with CVD and 34% and 7%, respectively, for those without CVD. CONCLUSIONS: Additional attention to traditional CV risk factors could yield further substantive reductions in CV events and mortality in adults with diabetes.
Authors: Mark C Hornbrook; Gene Hart; Jennifer L Ellis; Donald J Bachman; Gary Ansell; Sarah M Greene; Edward H Wagner; Roy Pardee; Mark M Schmidt; Ann Geiger; Amy L Butani; Terry Field; Hassan Fouayzi; Irina Miroshnik; Liyan Liu; Robert Diseker; Karen Wells; Rick Krajenta; Lois Lamerato; Christine Neslund Dudas Journal: J Natl Cancer Inst Monogr Date: 2005
Authors: Sophia Zoungas; John Chalmers; Bruce Neal; Laurent Billot; Qiang Li; Yoichiro Hirakawa; Hisatomi Arima; Helen Monaghan; Rohina Joshi; Stephen Colagiuri; Mark E Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Liu Lisheng; Giuseppe Mancia; Michel Marre; David R Matthews; Carl E Mogensen; Vlado Perkovic; Neil Poulter; Anthony Rodgers; Bryan Williams; Stephen MacMahon; Anushka Patel; Mark Woodward Journal: N Engl J Med Date: 2014-09-19 Impact factor: 91.245
Authors: Gregory A Nichols; Jay Desai; Jennifer Elston Lafata; Jean M Lawrence; Patrick J O'Connor; Ram D Pathak; Marsha A Raebel; Robert J Reid; Joseph V Selby; Barbara G Silverman; John F Steiner; W F Stewart; Suma Vupputuri; Beth Waitzfelder Journal: Prev Chronic Dis Date: 2012-06-07 Impact factor: 2.830
Authors: Sarah Stark Casagrande; Judith E Fradkin; Sharon H Saydah; Keith F Rust; Catherine C Cowie Journal: Diabetes Care Date: 2013-02-15 Impact factor: 19.112
Authors: Bishnu H Subedi; Parag H Joshi; Steven R Jones; Seth S Martin; Michael J Blaha; Erin D Michos Journal: Vasc Health Risk Manag Date: 2014-04-08
Authors: Connor Drake; Julienne K Kirk; John B Buse; David Edelman; Christopher M Shea; Susan Spratt; Laura A Young; Anna R Kahkoska Journal: N C Med J Date: 2019 Sep-Oct
Authors: Erik J M van Bommel; Marcel H A Muskiet; Lennart Tonneijck; Mark H H Kramer; Max Nieuwdorp; Daniel H van Raalte Journal: Clin J Am Soc Nephrol Date: 2017-03-02 Impact factor: 8.237
Authors: Magnus O Wijkman; Mary Dena; Sofia Dahlqvist; Sheyda Sofizadeh; Irl Hirsch; Jaakko Tuomilehto; Johan Mårtensson; Ole Torffvit; Henrik Imberg; Aso Saeed; Marcus Lind Journal: J Clin Hypertens (Greenwich) Date: 2018-12-05 Impact factor: 3.738